Apogee Therapeutics (NASDAQ:APGE – Get Free Report)‘s stock had its “outperform” rating restated by equities research analysts at William Blair in a report released on Monday, RTT News reports. They presently have a $40.00 price objective on the stock. William Blair’s target price suggests a potential upside of 70.21% from the stock’s previous close. A […]
Apogee Therapeutics (NASDAQ:APGE – Get Free Report) announced its quarterly earnings results on Monday. The company reported ($3.78) EPS for the quarter, missing analysts’ consensus estimates of ($2.49) by ($1.29), MarketWatch Earnings reports. Apogee Therapeutics Price Performance APGE opened at $23.50 on Wednesday. Apogee Therapeutics has a 1-year low of $19.98 and a 1-year high […]
Apogee Therapeutics (NASDAQ:APGE – Get Free Report) released its earnings results on Monday. The company reported ($3.78) EPS for the quarter, missing analysts’ consensus estimates of ($2.49) by ($1.29), MarketWatch Earnings reports. Apogee Therapeutics Trading Up 0.4 % Shares of Apogee Therapeutics stock traded up $0.09 on Wednesday, hitting $23.59. 30,420 shares of the company […]
Apogee Therapeutics (NASDAQ:APGE) Releases Earnings Results, Misses Expectations By $1 29 EPS modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.
Shares of Apogee Therapeutics, Inc. (NASDAQ:APGE – Get Free Report) have been given a consensus recommendation of “Buy” by the six analysts that are currently covering the firm, MarketBeat.com reports. Six analysts have rated the stock with a buy rating. The average twelve-month target price among brokerages that have issued ratings on the stock in […]